Skye Bioscience Inc - ESG Rating & Company Profile powered by AI
This page displays a zero-cost Sustainability report covering Skye Bioscience Inc. If you work at Skye Bioscience Inc and you would like to licence your Sustainability rating, please contact us. The ESG assessment for Skye Bioscience Inc indicates its reporting of the United Nations Sustainable Development Goals.
Skye Bioscience Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.1; made up of an environmental score of 3.2, social score of 6.0 and governance score of 6.0.
5.1
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 687 | Valbiotis SA | 5.2 | High |
| 687 | Zeria Pharmaceutical Co Ltd | 5.2 | High |
| 724 | Skye Bioscience Inc | 5.1 | High |
| 724 | Catalyst Pharmaceuticals Inc | 5.1 | High |
| 724 | Adverum Biotechnologies Inc | 5.1 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Skye Bioscience Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Skye Bioscience Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Skye Bioscience Inc report the average age of the workforce?
Sign up for free to unlockDoes Skye Bioscience Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Skye Bioscience Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Skye Bioscience Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Skye Bioscience Inc offer flexible work?
Sign up for free to unlockDoes Skye Bioscience Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Skye Bioscience Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Skye Bioscience Inc conduct supply chain audits?
Sign up for free to unlockDoes Skye Bioscience Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Skye Bioscience Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Skye Bioscience Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Skye Bioscience Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Skye Bioscience Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Skye Bioscience Inc disclose water use targets?
Sign up for free to unlockDoes Skye Bioscience Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Skye Bioscience Inc have a product recall in the last two years?
Sign up for free to unlockDoes Skye Bioscience Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Skye Bioscience Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Skye Bioscience Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Skye Bioscience Inc disclose parental leave metrics?
Sign up for free to unlockDoes Skye Bioscience Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Skye Bioscience Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Skye Bioscience Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Skye Bioscience Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Skye Bioscience Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Skye Bioscience Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Skye Bioscience Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Skye Bioscience Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Skye Bioscience Inc disclose its waste policy?
Sign up for free to unlockDoes Skye Bioscience Inc report according to TCFD requirements?
Sign up for free to unlockDoes Skye Bioscience Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Skye Bioscience Inc disclose energy use targets?
Sign up for free to unlockDoes Skye Bioscience Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Skye Bioscience Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Skye Bioscience Inc
These potential risks are based on the size, segment and geographies of the company.
Skye Bioscience, Inc., a biopharmaceutical company, discovers, develops, and commercializes cannabinoid-based therapeutics for the treatment of infectious diseases. The company's lead product candidate is THCVHS, which is in preclinical trials for the treatment of glaucoma. It is also developing CBDVHS that is in preclinical trials to treat various eye diseases, including uveitis, dry eye syndrome, macular degeneration and diabetic retinopathy; and Cannabinoid Cocktail for the treatment of anti-infective diseases. The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January 2021. Skye Bioscience, Inc. was founded in 2012 and is headquartered in San Diego, California.